ASLAN Pharmaceuticals Ltd (ASLN)
0.467
+0.01
(+1.74%)
USD |
NASDAQ |
May 02, 14:59
ASLAN Pharmaceuticals Total Liabilities (Quarterly): 37.91M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 37.91M |
| September 30, 2023 | 45.52M |
| June 30, 2023 | 48.84M |
| March 31, 2023 | 50.43M |
| December 31, 2022 | 52.82M |
| September 30, 2022 | 50.55M |
| June 30, 2022 | 47.95M |
| March 31, 2022 | 45.80M |
| December 31, 2021 | 37.21M |
| September 30, 2021 | 36.95M |
| June 30, 2021 | 20.67M |
| March 31, 2021 | 21.05M |
| December 31, 2020 | 26.23M |
| September 30, 2020 | 24.82M |
| Date | Value |
|---|---|
| June 30, 2020 | 22.96M |
| March 31, 2020 | 21.92M |
| December 31, 2019 | 23.95M |
| September 30, 2019 | 19.20M |
| June 30, 2019 | 21.21M |
| December 31, 2018 | 22.26M |
| September 30, 2018 | 16.94M |
| June 30, 2018 | 15.87M |
| March 31, 2018 | 25.36M |
| December 31, 2017 | 15.82M |
| September 30, 2017 | 11.61M |
| June 30, 2017 | 12.82M |
| March 31, 2017 | 12.95M |
| December 31, 2016 | 12.10M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
19.20M
Minimum
Sep 2019
52.82M
Maximum
Dec 2022
34.53M
Average
36.95M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| Dr Reddy's Laboratories Ltd | 1.258B |
| Concord Medical Services Holdings Ltd | 607.59M |
| WAVE Life Sciences Ltd | 235.32M |
| BeiGene Ltd | 2.268B |
| CytoMed Therapeutics Ltd | 0.8515M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 24.63M |
| Shareholders Equity (Quarterly) | -13.29M |